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INTRODUCTION
1. The publisher for this copyrighted material is Elsevier.  By clicking
"accept" in connection with completing this licensing transaction, you
agree that the following terms and conditions apply to this transaction
(along with the Billing and Payment terms and conditions established by
Copyright Clearance Center, Inc. ("CCC"), at the time that you opened your
Rightslink account and that are available at any time at
http://myaccount.copyright.com).
GENERAL TERMS
2. Elsevier hereby grants you permission to reproduce the aforementioned
material subject to the terms and conditions indicated.
3. Acknowledgement: If any part of the material to be used (for example,
figures) has appeared in our publication with credit or acknowledgement to
another source, permission must also be sought from that source.  If such
permission is not obtained then that material may not be included in your
publication/copies. Suitable acknowledgement to the source must be made,
either as a footnote or in a reference list at the end of your
publication, as follows:
"Reprinted from Publication title, Vol /edition number, Author(s), Title
of article / title of chapter, Pages No., Copyright (Year), with
permission from Elsevier [OR APPLICABLE SOCIETY COPYRIGHT OWNER]." Also
Lancet special credit - "Reprinted from The Lancet, Vol. number,
Author(s), Title of article, Pages No., Copyright (Year), with permission
from Elsevier."
4. Reproduction of this material is confined to the purpose and/or media
for which permission is hereby given.
5. Altering/Modifying Material: Not Permitted. However figures and
illustrations may be altered/adapted minimally to serve your work. Any
other abbreviations, additions, deletions and/or any other alterations
shall be made only with prior written authorization of Elsevier Ltd.
(Please contact Elsevier at permissions@elsevier.com). No modifications
can be made to any Lancet figures/tables and they must be reproduced in
full.
6. If the permission fee for the requested use of our material is waived
in this instance, please be advised that your future requests for Elsevier
materials may attract a fee.
7. Reservation of Rights: Publisher reserves all rights not specifically
granted in the combination of (i) the license details provided by you and
accepted in the course of this licensing transaction, (ii) these terms and
conditions and (iii) CCC's Billing and Payment terms and conditions.
8. License Contingent Upon Payment: While you may exercise the rights
licensed immediately upon issuance of the license at the end of the
licensing process for the transaction, provided that you have disclosed
complete and accurate details of your proposed use, no license is finally
effective unless and until full payment is received from you (either by
publisher or by CCC) as provided in CCC's Billing and Payment terms and
conditions.  If full payment is not received on a timely basis, then any
license preliminarily granted shall be deemed automatically revoked and
shall be void as if never granted.  Further, in the event that you breach
any of these terms and conditions or any of CCC's Billing and Payment
2017/3/8 RightsLink Printable License
https://s100.copyright.com/CustomerAdmin/PLF.jsp?ref=e33bf506­8bbf­4236­aba5­fa85c359b737 3/7
terms and conditions, the license is automatically revoked and shall be
void as if never granted.  Use of materials as described in a revoked
license, as well as any use of the materials beyond the scope of an
unrevoked license, may constitute copyright infringement and publisher
reserves the right to take any and all action to protect its copyright in
the materials.
9. Warranties: Publisher makes no representations or warranties with
respect to the licensed material.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher
and CCC, and their respective officers, directors, employees and agents,
from and against any and all claims arising out of your use of the
licensed material other than as specifically authorized pursuant to this
license.
11. No Transfer of License: This license is personal to you and may not be
sublicensed, assigned, or transferred by you to any other person without
publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except
in a writing signed by both parties (or, in the case of publisher, by CCC
on publisher's behalf).
13. Objection to Contrary Terms: Publisher hereby objects to any terms
contained in any purchase order, acknowledgment, check endorsement or
other writing prepared by you, which terms are inconsistent with these
terms and conditions or CCC's Billing and Payment terms and conditions. 
These terms and conditions, together with CCC's Billing and Payment terms
and conditions (which are incorporated herein), comprise the entire
agreement between you and publisher (and CCC) concerning this licensing
transaction.  In the event of any conflict between your obligations
established by these terms and conditions and those established by CCC's
Billing and Payment terms and conditions, these terms and conditions shall
control.
14. Revocation: Elsevier or Copyright Clearance Center may deny the
permissions described in this License at their sole discretion, for any
reason or no reason, with a full refund payable to you.  Notice of such
denial will be made using the contact information provided by you. 
Failure to receive such notice will not alter or invalidate the denial. 
In no event will Elsevier or Copyright Clearance Center be responsible or
liable for any costs, expenses or damage incurred by you as a result of a
denial of your permission request, other than a refund of the amount(s)
paid by you to Elsevier and/or Copyright Clearance Center for denied
permissions.
LIMITED LICENSE
The following terms and conditions apply only to specific license types:
15. Translation: This permission is granted for non-exclusive world
English rights only unless your license was granted for translation
rights. If you licensed translation rights you may only translate this
content into the languages you requested. A professional translator must
perform all translations and reproduce the content word for word
preserving the integrity of the article.
16. Posting licensed content on any Website: The following terms and
conditions apply as follows: Licensing material from an Elsevier journal:
All content posted to the web site must maintain the copyright information
line on the bottom of each image; A hyper-text must be included to the
Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx or the Elsevier
homepage for books at http://www.elsevier.com; Central Storage: This
license does not include permission for a scanned version of the material
to be stored in a central repository such as that provided by
Heron/XanEdu.
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Licensing material from an Elsevier book: A hyper-text link must be
included to the Elsevier homepage at http://www.elsevier.com . All content
posted to the web site must maintain the copyright information line on the
bottom of each image.
Posting licensed content on Electronic reserve: In addition to the above
the following clauses are applicable: The web site must be password-
protected and made available only to bona fide students registered on a
relevant course. This permission is granted for 1 year only. You may
obtain a new license for future website posting.
17. For journal authors: the following clauses are applicable in addition
to the above:
Preprints:
A preprint is an author's own write-up of research results and analysis,
it has not been peer-reviewed, nor has it had any other value added to it
by a publisher (such as formatting, copyright, technical enhancement
etc.).
Authors can share their preprints anywhere at any time. Preprints should
not be added to or enhanced in any way in order to appear more like, or to
substitute for, the final versions of articles however authors can update
their preprints on arXiv or RePEc with their Accepted Author Manuscript
(see below).
If accepted for publication, we encourage authors to link from the
preprint to their formal publication via its DOI. Millions of researchers
have access to the formal publications on ScienceDirect, and so links will
help users to find, access, cite and use the best available version.
Please note that Cell Press, The Lancet and some society-owned have
different preprint policies. Information on these policies is available on
the journal homepage.
Accepted Author Manuscripts: An accepted author manuscript is the
manuscript of an article that has been accepted for publication and which
typically includes author-incorporated changes suggested during
submission, peer review and editor-author communications.
Authors can share their accepted author manuscript:
-         immediately
via their non-commercial person homepage or blog
by updating a preprint in arXiv or RePEc with the accepted
manuscript
via their research institute or institutional repository for
internal institutional uses or as part of an invitation-
only research collaboration work-group
directly by providing copies to their students or to research
collaborators for their personal use
for private scholarly sharing as part of an invitation-only
work group on commercial sites with which Elsevier has an
agreement
-         after the embargo period
via non-commercial hosting platforms such as their
institutional repository
via commercial sites with which Elsevier has an agreement
In all cases accepted manuscripts should:
-         link to the formal publication via its DOI
-         bear a CC-BY-NC-ND license - this is easy to do
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-         if aggregated with other manuscripts, for example in a repository or
other site, be shared in alignment with our hosting policy not be
added to or enhanced in any way to appear more like, or to substitute
for, the published journal article.
Published journal article (JPA): A published journal article (PJA) is the
definitive final record of published research that appears or will appear
in the journal and embodies all value-adding publishing activities
including peer review co-ordination, copy-editing, formatting, (if
relevant) pagination and online enrichment.
Policies for sharing publishing journal articles differ for subscription
and gold open access articles:
Subscription Articles: If you are an author, please share a link to your
article rather than the full-text. Millions of researchers have access to
the formal publications on ScienceDirect, and so links will help your
users to find, access, cite, and use the best available version.
Theses and dissertations which contain embedded PJAs as part of the formal
submission can be posted publicly by the awarding institution with DOI
links back to the formal publications on ScienceDirect.
If you are affiliated with a library that subscribes to ScienceDirect you
have additional private sharing rights for others' research accessed under
that agreement. This includes use for classroom teaching and internal
training at the institution (including use in course packs and courseware
programs), and inclusion of the article for grant funding purposes.
Gold Open Access Articles: May be shared according to the author-selected
end-user license and should contain a CrossMark logo, the end user
license, and a DOI link to the formal publication on ScienceDirect.
Please refer to Elsevier's posting policy for further information.
18. For book authors the following clauses are applicable in addition to
the above:   Authors are permitted to place a brief summary of their work
online only. You are not allowed to download and post the published
electronic version of your chapter, nor may you scan the printed edition
to create an electronic version. Posting to a repository: Authors are
permitted to post a summary of their chapter only in their institution's
repository.
19. Thesis/Dissertation: If your license is for use in a
thesis/dissertation your thesis may be submitted to your institution in
either print or electronic form. Should your thesis be published
commercially, please reapply for permission. These requirements include
permission for the Library and Archives of Canada to supply single copies,
on demand, of the complete thesis and include permission for Proquest/UMI
to supply single copies, on demand, of the complete thesis. Should your
thesis be published commercially, please reapply for permission. Theses
and dissertations which contain embedded PJAs as part of the formal
submission can be posted publicly by the awarding institution with DOI
links back to the formal publications on ScienceDirect.
 
Elsevier Open Access Terms and Conditions
You can publish open access with Elsevier in hundreds of open access
journals or in nearly 2000 established subscription journals that support
open access publishing. Permitted third party re-use of these open access
articles is defined by the author's choice of Creative Commons user
license. See our open access license policy for more information.
Terms & Conditions applicable to all Open Access articles published with
Elsevier:
Any reuse of the article must not represent the author as endorsing the
adaptation of the article nor should the article be modified in such a way
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as to damage the author's honour or reputation. If any changes have been
made, such changes must be clearly indicated.
The author(s) must be appropriately credited and we ask that you include
the end user license and a DOI link to the formal publication on
ScienceDirect.
If any part of the material to be used (for example, figures) has appeared
in our publication with credit or acknowledgement to another source it is
the responsibility of the user to ensure their reuse complies with the
terms and conditions determined by the rights holder.
Additional Terms & Conditions applicable to each Creative Commons user
license:
CC BY: The CC-BY license allows users to copy, to create extracts,
abstracts and new works from the Article, to alter and revise the Article
and to make commercial use of the Article (including reuse and/or resale
of the Article by commercial entities), provided the user gives
appropriate credit (with a link to the formal publication through the
relevant DOI), provides a link to the license, indicates if changes were
made and the licensor is not represented as endorsing the use made of the
work. The full details of the license are available at
http://creativecommons.org/licenses/by/4.0.
CC BY NC SA: The CC BY-NC-SA license allows users to copy, to create
extracts, abstracts and new works from the Article, to alter and revise
the Article, provided this is not done for commercial purposes, and that
the user gives appropriate credit (with a link to the formal publication
through the relevant DOI), provides a link to the license, indicates if
changes were made and the licensor is not represented as endorsing the use
made of the work. Further, any new works must be made available on the
same conditions. The full details of the license are available at
http://creativecommons.org/licenses/by-nc-sa/4.0.
CC BY NC ND: The CC BY-NC-ND license allows users to copy and distribute
the Article, provided this is not done for commercial purposes and further
does not permit distribution of the Article if it is changed or edited in
any way, and provided the user gives appropriate credit (with a link to
the formal publication through the relevant DOI), provides a link to the
license, and that the licensor is not represented as endorsing the use
made of the work. The full details of the license are available at
http://creativecommons.org/licenses/by-nc-nd/4.0. Any commercial reuse of
Open Access articles published with a CC BY NC SA or CC BY NC ND license
requires permission from Elsevier and will be subject to a fee.
Commercial reuse includes:
-         Associating advertising with the full text of the Article
-         Charging fees for document delivery or access
-         Article aggregation
-         Systematic distribution via e-mail lists or share buttons
Posting or linking by commercial companies for use by customers of those
companies.
 
20. Other Conditions:
 
v1.9
Questions? customercare@copyright.com or +1­855­239­3415 (toll free in the US) or
+1­978­646­2777.
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